Securities code: 000516 securities abbreviation: St Guoyi Announcement No.: 2022-004 Xi’An International Medical Investment Company Limited(000516)
Stock trading abnormal fluctuation announcement
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
1、 Introduction to abnormal fluctuations in stock trading
Xi’An International Medical Investment Company Limited(000516) (hereinafter referred to as “the company”) (Securities abbreviation: St Guoyi, securities code: 000516) the deviation of the closing price increase for two consecutive trading days on January 20 and January 21, 2022 has reached 12.25%. According to the relevant provisions of Shenzhen Stock Exchange, it belongs to abnormal fluctuation of stock trading.
2、 The company pays attention to and verifies the situation
In view of the abnormal fluctuation of the company’s shares, the company has conducted necessary verification on relevant matters, and the relevant information is explained as follows:
1. According to the notice of Xi’an Health Committee on the handling of Xi’an high tech hospital and Xi’an Xi’An International Medical Investment Company Limited(000516) central hospital issued by Xi’an Health Committee on January 13, 2022, Xi’an high tech hospital (hereinafter referred to as “high tech hospital”) and Xi’an Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as “Central Hospital”) subordinate to the company are closed for rectification for 3 months, Treatment opinions such as reopening after the rectification is qualified at the expiration of the period.
2. On January 14, 2022, the company disclosed the announcement on the subordinate hospitals receiving the handling notice of Xi’an Health Commission and the suggestive announcement on the implementation of other risk warnings on the company’s shares and the suspension of the company’s shares in the securities times, China Securities News, Shanghai Securities News, Securities Daily and cninfo.com. High tech hospital and central hospital will be closed for rectification for three months, which is expected to have a significant impact on the company’s operating performance in 2022. According to article 9.8.1 of the stock listing rules of Shenzhen Stock Exchange (revised in 2022), this event triggered the corresponding situation of “other risk warnings for the shares of listed companies”. Since the opening of the company’s stock market on January 17, 2022, other risk warnings have been implemented. The abbreviation of the company’s stock has been changed from ” Xi’An International Medical Investment Company Limited(000516) ” to “St Guoyi”, the stock code is still “000516”, and the rise and fall of the stock trading day is limited to 5%.
3. Recently, the public media reported the above matters and announcements of the company, which had a certain impact on the stock trading price of the company.
4. The company, its controlling shareholders and actual controllers do not have any major events that should be disclosed but not disclosed, nor do they have any major events in the planning stage.
5. The controlling shareholder and actual controller of the company did not buy or sell the company’s shares during the abnormal fluctuation of the company’s stock trading.
6. There is no need to correct or supplement the information disclosed by the company in the early stage.
3、 Whether there is a description of information that should be disclosed but not disclosed
The board of directors of the company confirms that the company has no undisclosed matters or planning, negotiation, intention, agreement, etc. related to the matters that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions; The board of directors has not been informed that the company has undisclosed information that should be disclosed in accordance with the stock listing rules of Shenzhen Stock Exchange and other relevant provisions and has a great impact on the stock trading price of the company; There is no need to correct or supplement the information disclosed by the company in the early stage.
4、 Necessary risk tips
1. After self-examination, the company does not violate the fair disclosure of information.
2. The company solemnly reminds investors: securities times, China Securities News, Shanghai Securities News, securities daily and cninfo（ http://www.cn.info.com.cn. ）As the information disclosure media designated by the company, all information of the company shall be subject to the information published in the above designated media. Investors are invited to invest rationally and pay attention to risks.
It is hereby announced.
Xi’An International Medical Investment Company Limited(000516) board of directors January 24, 2002
